Anti-ISK13/ SPINK13/ HBVDNAPTP1 functional antibody

Anti-ISK13/ SPINK13/ HBVDNAPTP1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SPINK13/SPINK13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0480-Ab-1/ GM-Tg-hg-SE0480-Ab-2Anti-Human SPINK13 monoclonal antibodyHuman
GM-Tg-rg-SE0480-Ab-1/ GM-Tg-rg-SE0480-Ab-2Anti-Rat SPINK13 monoclonal antibodyRat
GM-Tg-mg-SE0480-Ab-1/ GM-Tg-mg-SE0480-Ab-2Anti-Mouse SPINK13 monoclonal antibodyMouse
GM-Tg-cynog-SE0480-Ab-1/ GM-Tg-cynog-SE0480-Ab-2Anti-Cynomolgus/ Rhesus macaque SPINK13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0480-Ab-1/ GM-Tg-felg-SE0480-Ab-2Anti-Feline SPINK13 monoclonal antibodyFeline
GM-Tg-cang-SE0480-Ab-1/ GM-Tg-cang-SE0480-Ab-2Anti-Canine SPINK13 monoclonal antibodyCanine
GM-Tg-bovg-SE0480-Ab-1/ GM-Tg-bovg-SE0480-Ab-2Anti-Bovine SPINK13 monoclonal antibodyBovine
GM-Tg-equg-SE0480-Ab-1/ GM-Tg-equg-SE0480-Ab-2Anti-Equine SPINK13 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0480-Ab-1/ GM-Tg-hg-SE0480-Ab-2; GM-Tg-rg-SE0480-Ab-1/ GM-Tg-rg-SE0480-Ab-2;
GM-Tg-mg-SE0480-Ab-1/ GM-Tg-mg-SE0480-Ab-2; GM-Tg-cynog-SE0480-Ab-1/ GM-Tg-cynog-SE0480-Ab-2;
GM-Tg-felg-SE0480-Ab-1/ GM-Tg-felg-SE0480-Ab-2; GM-Tg-cang-SE0480-Ab-1/ GM-Tg-cang-SE0480-Ab-2;
GM-Tg-bovg-SE0480-Ab-1/ GM-Tg-bovg-SE0480-Ab-2; GM-Tg-equg-SE0480-Ab-1/ GM-Tg-equg-SE0480-Ab-2
Products NameAnti-SPINK13 monoclonal antibody
Formatmab
Target NameSPINK13
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SPINK13 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0480-Ag-1Recombinant multi-species ISK13/ SPINK13/ HBVDNAPTP1 protein
    ORF Viral VectorpGMLP004365human SPINK13 Lentivirus plasmid
    ORF Viral VectorvGMLP004365human SPINK13 Lentivirus particle
    ORF Viral VectorpGMLPm003297mouse Spink13 Lentivirus plasmid
    ORF Viral VectorvGMLPm003297mouse Spink13 Lentivirus particle


    Target information

    Target IDGM-SE0480
    Target NameSPINK13
    Gene ID153218,100038417,689570,100329159,104972860
    Gene Symbol and SynonymsGm10534,HBVDNAPTP1,HESPINTOR,LiESP6,SPINK13,SPINK5L3
    Uniprot AccessionQ1W4C9,D3ZVP0
    Uniprot Entry NameISK13_HUMAN,ISK13_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000214510
    Target ClassificationN/A

    The target: SPINK13, gene name: SPINK13, also named as HBVDNAPTP1, HESPINTOR, LiESP6, SPINK5L3. Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in negative regulation of acrosome reaction. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.